We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Shanghai-based Junshi Biosciences announced that it has finished enrolling participants in a phase 1 trial of JS016, its COVID-19 neutralizing antibody. Read More
Even in the midst of the COVID-19 pandemic, some drugmakers have continued to impose price hikes, raising the list prices for 42 branded drugs by an average of 3.5 percent in July so far, according to a drug price watchdog. Read More
FDA Commissioner Stephen Hahn said Friday that the agency will resume domestic inspections this month using a new risk assessment system developed in response to the pandemic. Read More
The FDA has handed Mylan and Fujifilm Kyowa Kirin Biologics approval for their biosimilar of Humira (adalimumab), marking the agency’s sixth approval for a biosimilar of AbbVie’s blockbuster immunosuppressive drug. Read More